<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?>
<data_table id="pht000205.v2" study_id="phs000115.v6" participant_set="4" date_created="Fri Sep 25 16:48:01 2009">

<variable id="phv00024681.v2">
	<name>IDTYPE</name>
	<description>COHORT IDENTIFIER</description>
	<value code="0">ORIGINAL COHORT GROUP</value>
	<value code="1">OFFSPRING GROUP</value>
	<value code="3">GENERATION 3</value>
</variable>

<variable id="phv00024682.v2">
	<name>CHYLO</name>
	<description>CHYLOMICRON PARTICLES SIZE &gt; 220 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024683.v2">
	<name>VLDLP6</name>
	<description>VLDL PARTICLES SIZE 150+/-70 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024684.v2">
	<name>VLDLP5</name>
	<description>VLDL PARTICLES SIZE 70+/-10 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024685.v2">
	<name>VLDLP4</name>
	<description>VLDL PARTICLES SIZE 50+/-10 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024686.v2">
	<name>VLDLP3</name>
	<description>VLDL PARTICLES SIZE 38+/-3 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024687.v2">
	<name>VLDLP2</name>
	<description>VLDL PARTICLES SIZE 33+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024688.v2">
	<name>VLDLP1</name>
	<description>VLDL PARTICLES SIZE 29+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024689.v2">
	<name>IDLP</name>
	<description>IDL PARTICLES 25+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024690.v2">
	<name>LDLP3</name>
	<description>LDL PARTICLES 22+/-0.7 NM 
 (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024691.v2">
	<name>LDLP2</name>
	<description>LDL PARTICLES 20.5+/-0.7 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024692.v2">
	<name>LDLP1</name>
	<description>LDL PARTICLES 19+/-0.7 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024693.v2">
	<name>HDLP5</name>
	<description>HDL PARTICLES 11.5+/-1.5 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024694.v2">
	<name>HDLP4</name>
	<description>HDL PARTICLES 9.4+/-0.6 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024695.v2">
	<name>HDLP3</name>
	<description>HDL PARTICLES 8.5+/-0.3 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024696.v2">
	<name>HDLP2</name>
	<description>HDL PARTICLES 8.0+/-0.2 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024697.v2">
	<name>HDLP1</name>
	<description>HDL PARTICLES 7.5+/-0.2 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024698.v2">
	<name>VLDLSZ</name>
	<description>WEIGHTED AVERAGE FOR VLDL SIZE BASED ON MEASUREMENTS OF VLDLP1 THROUGH VLDLP6, EXAM 4</description>
</variable>

<variable id="phv00024699.v2">
	<name>LDLSZ</name>
	<description>WEIGHTED AVERAGE FOR LDL SIZE BASED ON MEASUREMENTS OF LDLP1 THROUGH LDLP6, EXAM 4</description>
</variable>

<variable id="phv00024700.v2">
	<name>HDLSZ</name>
	<description>WEIGHTED AVERAGE FOR HDL SIZE BASED ON MEASUREMENTS OF HDLP1 THROUGH HDLP6, EXAM 4</description>
</variable>

<variable id="phv00024701.v2">
	<name>APOCIIIT</name>
	<description>APOLIPOPROTEIN CIII CONCENTRATION DETERMINED USING NEPHELOMETRIC ASSAY FROM WACO (MG/DL), EXAM 5</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024702.v2">
	<name>APOA14</name>
	<description>APOLIPOPROTEIN AI CONCENTRATION USING ELISA (MG/DL), EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024703.v2">
	<name>APOB4</name>
	<description>APOLIPOPPROTEIN B CONCENTRATION USING ELISA (MG/DL), EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024704.v2">
	<name>RLP_C</name>
	<description>REMNANT LIKE PARTICLES MEASURED USING SELECTIVE IMMUNOSEPARATION OF LIPOPROTEINS USING THE OTSHUKA KIT. EXPRESSED AS CHOLESTEROL IN MG/DL, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024705.v2">
	<name>RLP_TG</name>
	<description>REMNANT LIKE PARTICLES MEASURED USING SELECTIVE IMMUNOSEPARATION OF LIPOPROTEINS USING THE OTSHUKA KIT. EXPRESSED AS TRIGLYCERIDES IN MG/DL, EXAM 4</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024706.v2">
	<name>APOESER5</name>
	<description>APOE CONCENTRATIONS IN MG/DL USING IMMUNOCHEMICAL TECHNIQUE BY SERVIA, EXAM 5</description>
	<unit>MG/DL</unit>
</variable>

<variable id="phv00024707.v2">
	<name>shareid</name>
	<description>UNIQUE PARTICIPANT ID</description>
</variable>

</data_table>
